Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000887017 | SCV001030554 | likely benign | Specific granule deficiency | 2024-12-24 | criteria provided, single submitter | clinical testing | |
New York Genome Center | RCV002227502 | SCV002506625 | uncertain significance | Specific granule deficiency 1 | 2021-05-21 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003424445 | SCV004117673 | uncertain significance | CEBPE-related disorder | 2023-09-12 | criteria provided, single submitter | clinical testing | The CEBPE c.842G>A variant is predicted to result in the amino acid substitution p.Ser281Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.26% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-23586700-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |